Dosage Forms

Feliza Mirasol is the science editor for 

Videos

At AAPS PharmSci 360, Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics.

AAPS PharmSci 360: LBFs and Tackling Oral Biologic Formulations

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between companies, and across scientific disciplines, to work together on continuing to develop medicines to save lives.

AAPS PharmSci 360 2024: The Future of Bioanalysis

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Pharmaceutical Technology® Europe sat down with Hanns-Christian Mahler from ten23 health to discuss the fill/finish market and sustainability considerations for facilities.

CPHI Milan 2024: Fill/Finish and Sustainability

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

The best strategy is to use a combination of complementary methods.

Glycosylation Analysis for Multispecifics

Mike Hennessy Jr. is the President and CEO of 

A greater number of patients with Duchenne muscular dystrophy will be able to be treated after FDA's approval of a gene therapy.

Publisher's Note: With Age Comes Wisdom

Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.

Finding a More Optimal Way for ATMPs (BIO 2024)

Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.

Exploring the Potential of mRNA (BIO 2024) 

Pharm Tech Group chats with Dr. Monika Paulė, CEO and co-founder of Caszyme about the evolution of CRISPR.

Seeking Excellence with CRISPR (BIO 2024)

Michaela Doláková is chief microbiologist at SCTbio.

Veronika Horková is microbiologist at SCTbio.

Klára Sochorová is senior quality compliance manager at SCTbio.

Daniela Rožková is chief technology officer at SCTbio.

A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.

Rapid Sterility Methods for CAR T-cell Therapies

The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product. 

Biologic Drugs